People · Operator
Named in public records as an officer, director or promoter · active 2010–2010 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vaxgen Inc | — | Biotechnology | Series A | $5.2M | $187.6M | 2010 |
| Diadexus Inc | — | Biotechnology | Series A | $4.5M | $162.7M | 2010 |
David J. Foster at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David J. Foster on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Louis C. Bock | 2 | 7 |
| Charles W. Patrick | 2 | 3 |
| Bernard M. Alfano | 2 | 2 |
| James P. Panek | 1 | 1 |
| Robert L. Wolfert | 1 | 1 |
| Robert L. Wolfert, Ph.D. | 1 | 1 |
| Michael C Goller | 1 | 1 |
| Kelvin C Neu, MD | 1 | 1 |
| Patrick Plewman | 1 | 1 |
| Lori F. Rafield | 1 | 1 |
| Patrick F. Plewman | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.